.png)
Quick answer — Most pet supplements and functional pet foods in Australia do not need APVMA registration, provided they qualify as Excluded Nutritional or Digestive (END) products under the Agvet Code. Qualification depends on passing four tests covering ingredients, claims, labelling, and manufacturing. The critical test is claims: a product that says "supports joint health" is likely excluded, while one that says "treats arthritis" has crossed into therapeutic territory and requires registration. But even when APVMA does not apply, the Australian Consumer Law still does, and every health claim still needs substantiation the ACCC could ask you to produce.
The pet supplement market in Australia is growing fast, and the brands entering it are making increasingly specific health claims on packaging, websites, and social media. Joint support, gut health, skin and coat, calming, cognitive function for senior dogs. The marketing language is getting bolder, but most brands have not mapped the regulatory picture clearly enough to know whether their claims are compliant, exposed, or somewhere in between. This post walks through the three regulators that govern pet health claims in Australia, explains the framework that determines whether your product needs APVMA registration, and sets out what a defensible pet supplement claim actually looks like in practice.
Who actually regulates pet health claims in Australia?
There is no single regulator responsible for pet supplement and pet food health claims in Australia. Three bodies share the space, and each one cares about different things.
The Australian Pesticides and Veterinary Medicines Authority (APVMA) regulates veterinary chemical products, which includes feed medications, supplements, and additives. If your product makes a therapeutic claim, or if it contains certain active constituents, it almost certainly needs APVMA registration before it can legally be sold. The APVMA's remit runs up to and including the point of retail sale.
The Australian Competition and Consumer Commission (ACCC) enforces the Australian Consumer Law (ACL), which prohibits misleading or deceptive conduct in trade or commerce. This applies to every pet product on the market regardless of whether it falls within APVMA's scope. If your label says "premium salmon recipe" but the primary ingredients are chicken and beef, the ACCC can and will act. If your packaging claims a calming effect on anxious dogs and you have no evidence to support that, the ACL applies even if APVMA registration is not required.
The gap worth noting is that Australia has no mandatory federal standard for pet food. The Australian Standard AS 5812 covers manufacturing and labelling, but adoption is voluntary. A Senate committee has recommended expanding mandatory oversight, and that recommendation has not gone away. The practical consequence is that ACL is currently doing most of the heavy lifting on pet health claims, often without the sector realising it.
For brands entering this market, the question is not "which regulator applies?" but "which combination of regulators applies, and have I satisfied all of them?"
The END product framework: four tests that decide everything
The APVMA introduced the Excluded Nutritional or Digestive (END) product framework in 2015 to reduce the regulatory burden on animal feed products that pose low risk. Under this framework, a pet food or supplement that is fed to and voluntarily consumed by an animal can be excluded from APVMA registration if it passes four tests.
Test 1: Ingredients. The product must not contain certain prohibited ingredients, including antibiotics listed in schedules 2, 3, 4, 7, 8, or 9 of the Poisons Standard. Every ingredient must appear on at least one of the specified Generally Recognised as Safe (GRAS) lists. If your product contains a novel ingredient that is not on these lists, it cannot qualify as an END product.
Test 2: Claims. This is the test that trips most brands up. If the product does not make therapeutic claims, it is excluded from the legislation. If the product does make a therapeutic claim, it is not excluded unless those claims are supported by scientific evidence that is accessible to the supplier, of a standard suitable for publication in recognised peer-reviewed journals, and available to the APVMA on request. Alternatively, the product can be excluded if it is supplied only through a treating veterinarian who supports the claims.
Test 3: Labelling. The product label must contain specific information including application or dosage rate, instructions for use, analysis of key ingredients to support any claims, a list of ingredients, and batch number and expiry date.
Test 4: Manufacturing. The product must be manufactured under an approved quality assurance system. Acceptable QA systems include APVMA Good Manufacturing Practice, an Australian animal feed industry QA programme such as FeedSafe or FAMI-QS, the Australian Standard AS 5812-2023, or an equivalent US or EU feed quality standard. The QA system must be appropriate to the product type, so a stockfeed QA system will not satisfy this test for a pet food.
Pass all four and your product sits outside APVMA's registration requirements. Fail any one of them and you may need to register before you can legally sell.
Where the claim line sits: nutritional message versus therapeutic claim
The claims test is where most of the commercial risk concentrates, because the line between a nutritional message and a therapeutic claim is narrower than most marketing teams assume.
The APVMA publishes guidance on what it considers acceptable nutritional messages for animal feed products. These include statements about what a product contains (protein source, mineral content, caloric content), general health messages referring to maintenance of normal healthy organs or physiological systems, and specific nutritional messages relating to particular ingredients. "High protein," "rich in omega-3 fatty acids," and "supports healthy skin and coat" are all in nutritional territory.
Therapeutic claims are different. A therapeutic claim represents a product as being suitable for, used for, or capable of curing, preventing, or treating a disease, condition, or injury. "Treats arthritis," "reduces anxiety," "prevents hip dysplasia," and "cures digestive disorders" are all clearly therapeutic and will require either APVMA registration or supply through a veterinarian with supporting evidence.
The APVMA's own guidance uses Vitamin E as an instructive example of how the same ingredient can sit on either side of the line depending on how the claim is framed. When Vitamin E is added to animal feed "to supplement diets where levels may be low," it is an excluded feed supplement. When it is added to cure a non-specific disease or condition resulting from a dietary deficiency, it becomes a complementary animal health product. And when it is added to cure white muscle disease in lambs or tying-up in horses, it is a pharmaceutical veterinary medicine. Same ingredient, three different regulatory classifications, entirely determined by the claim.
For pet supplement brands, the practical implication is that claim wording is not a marketing decision that can be made independently of regulatory strategy. The words on your label and your website determine which regulatory framework applies to your product, and getting this wrong can mean selling an unregistered veterinary chemical product, which is an offence under the Agvet Code.
How Australia, New Zealand, and the US handle pet supplement claims differently
If you are selling or planning to sell across multiple markets, the regulatory logic is not the same in each country, and the differences are not just procedural. They change which claims you can make, which evidence you need, and where the real enforcement risk sits.
Australia uses the APVMA and the END product framework described above. Pet supplements that pass the four tests (ingredients, claims, labelling, manufacturing) are excluded from APVMA registration, and the Australian Consumer Law fills the remaining gap. The system is relatively clear once you understand the END framework, but the absence of a mandatory federal pet food standard means that ACL's general prohibition on misleading conduct does most of the actual enforcement work. The claim line between nutritional and therapeutic is well documented in APVMA guidance, and the Vitamin E example gives brands a practical model for how to frame claims safely.
New Zealand regulates pet supplements under the Agricultural Compounds and Veterinary Medicines (ACVM) Act 1997, administered by the Ministry for Primary Industries (MPI). Pet foods, animal feeds, and nutritional supplements are classified as oral nutritional compounds (ONCs) and are normally exempt from ACVM registration because they pose relatively low risk. The exemption holds as long as the product meets the conditions in the ACVM Regulations, including a prohibition under Regulation 13 on making therapeutic or pharmacological claims. So you cannot state that your product "treats arthritis" or "prevents hip dysplasia" without triggering registration as a veterinary medicine. Manufacturers must also maintain a documented manufacturing system, meet labelling requirements, and avoid including nutrient levels above those necessary for the maintenance of health. The conceptual parallel with Australia's END framework is clear, but the mechanism is different: New Zealand uses a blanket exemption with conditions rather than a four-part test, and MPI is explicit that exemption from registration does not mean exemption from regulation.
The United States is the most fragmented of the three. Pet supplements have no defined statutory category under US federal law. The Dietary Supplement Health and Education Act (DSHEA), which created the framework for human dietary supplements in 1994, does not apply to animals, and the FDA confirmed this position in 1996. This means pet supplements sit in a regulatory gap between animal food (regulated by the FDA's Centre for Veterinary Medicine and state feed control officials through AAFCO model regulations) and animal drugs (which require a New Animal Drug Application). Structure/function claims are permitted on pet food when they relate to taste, aroma, or nutritive value, but any claim that implies a product can diagnose, cure, mitigate, treat, or prevent disease is classified as a drug claim and triggers FDA approval requirements. The National Animal Supplement Council (NASC) has built a voluntary compliance infrastructure including quality seals, adverse event reporting, and labelling standards that many manufacturers use as a practical baseline. But the patchwork of state-level enforcement remains a significant pain point: requirements vary widely, and companies selling nationally may need to maintain multiple label versions. The NASC is currently advancing the Animal Health Supplement Act through Congress to create the statutory clarity the category lacks, but until that legislation passes, the US market remains harder to navigate than either Australia or New Zealand.
The practical takeaway for brands operating across these markets is that while the underlying principle is consistent (nutritional claims are generally permitted, therapeutic claims trigger higher regulatory requirements), the mechanisms, the evidence thresholds, and the enforcement postures differ enough that a claim set developed for one market cannot be assumed compliant in another. A cross-market claims strategy needs to be mapped jurisdiction by jurisdiction, and the evidence file needs to satisfy the most demanding of the three.
Why ACL is the regulator that catches most pet brands
Many pet supplement brands focus their compliance effort on the APVMA question, reasoning that once they have confirmed their product does not need registration, they are in the clear. This is a dangerous assumption, because the Australian Consumer Law applies to every pet product regardless of its APVMA status.
The ACL requires that any claim made about a product in trade or commerce must not be misleading or deceptive, and the business making the claim must be able to substantiate it. The ACCC does not need to prove that a consumer was actually misled, only that the conduct was likely to mislead or deceive. The test the courts apply is "what is the dominant impression created by the statement?" which means that even a literally true statement can breach the ACL if the overall impression it creates is false.
For pet supplement brands, this means that "supports joint health" needs supporting evidence even though it does not require APVMA registration. "Veterinarian recommended" needs documentation that a veterinarian actually recommended it. "Premium" and "organic" need to be substantiated. "Australian made" or "Australian sourced" need to accurately reflect the origin of the ingredients, not just the location of final packaging. The ACCC has shown it will act on ingredient origin claims in the supplement space, as the Wealthy Health squalene undertaking demonstrated.
The absence of a mandatory federal pet food standard makes this dynamic more pronounced. Without a prescriptive regulatory framework setting minimum evidence thresholds for specific claim types, the ACL's general prohibition on misleading conduct becomes the primary constraint. Brands that treat substantiation as optional because their product sits outside APVMA's scope are building on an assumption that will not survive scrutiny.
What a defensible pet supplement claim looks like
Building a defensible claim for a pet supplement or functional pet food means satisfying three requirements simultaneously: staying on the right side of the APVMA's claim line, meeting the ACL's substantiation standard, and communicating something that actually matters to the consumer.
Match the claim strength to the evidence you hold. If you have robust clinical data showing that your formulation improves coat condition in dogs, say so precisely and reference the data. If you have ingredient-level evidence from published literature but no product-specific trial, you can make a softer claim about the ingredient's known nutritional role but you should not imply product-level efficacy. If you have mechanism-of-action data from in-vitro studies but nothing in-vivo, acknowledge that the evidence supports a plausible nutritional benefit rather than a proven therapeutic outcome.
Stay on the nutritional side of the line unless you are prepared to register. Use the APVMA's acceptable nutritional messages guidance as your claim vocabulary. Frame benefits in terms of maintenance and support rather than treatment and cure. "Formulated with glucosamine to support healthy joint function" is nutritional. "Glucosamine formula for treating joint pain" is therapeutic. The difference between those two sentences is the difference between an END product and an unregistered veterinary medicine.
Substantiate regardless of which regulator applies. Assume that the ACCC could ask you tomorrow to produce the evidence supporting every claim on your label, your website, and your social media. If you cannot produce it, the claim is not defensible regardless of its APVMA status. Build the evidence file before you write the copy, not after.
Treat label compliance as a minimum, not a ceiling. The labelling test in the END framework requires specific information on the product label. Meet that requirement, but also apply the same discipline to your digital marketing. The ACCC's enforcement scope extends to websites, social media, and marketplace listings, not just physical packaging.
For brands entering the Australian pet supplement market or expanding their claim set, the regulatory picture is genuinely navigable. The END framework provides a clear path to market for products that meet its four tests, and the ACL's substantiation requirement is not unreasonable once you have mapped your evidence against your claims. The brands that get into trouble are almost always the ones that wrote the marketing copy first and asked the regulatory questions later.
Frequently asked questions
Do pet supplements need to be registered with the APVMA in Australia?
Not necessarily. Pet supplements can be excluded from APVMA registration if they qualify as Excluded Nutritional or Digestive (END) products under the Agvet Code. To qualify, the product must pass four tests covering ingredients, claims, labelling, and manufacturing. The most critical test is claims: products that make only nutritional claims are generally excluded, while products making therapeutic claims (treating, curing, or preventing a disease or condition) will typically require registration unless the claims are backed by peer-reviewed scientific evidence and the product is supplied through a veterinarian.
What is the difference between a nutritional claim and a therapeutic claim for pet products?
A nutritional claim describes what a product contains or states that it supports the maintenance of normal health, production, or performance. Examples include "high in omega-3 fatty acids" or "supports healthy skin and coat." A therapeutic claim represents a product as suitable for treating, curing, or preventing a disease, condition, or injury. Examples include "treats arthritis" or "prevents hip dysplasia." The distinction matters because therapeutic claims generally trigger APVMA registration requirements, while nutritional claims can fall within the END product exclusion.
What is an END product under the Agvet Code?
An END product is an Excluded Nutritional or Digestive product, a category created by the 2015 reforms to the Agricultural and Veterinary Chemicals Code Regulations. END products are animal feed products, including pet foods and supplements, that are excluded from APVMA registration because they meet four specified requirements covering ingredients (GRAS-listed, no prohibited substances), claims (no unsupported therapeutic claims), labelling (specified information present), and manufacturing (produced under an approved QA system). The framework was designed to reduce regulatory burden on low-risk nutritional products.
Does the ACCC regulate pet food claims even if the product doesn't need APVMA registration?
Yes. The Australian Consumer Law, enforced by the ACCC, applies to every product sold in Australia regardless of its APVMA registration status. Any claim made about a pet food or supplement must not be misleading or deceptive, and the business must be able to substantiate the claim if asked. This includes claims on packaging, websites, social media, and marketplace listings. Brands that assume they are in the clear because they sit outside APVMA's scope are missing the regulator that is most likely to act on unsubstantiated pet health claims.
What evidence do I need to substantiate a pet supplement claim?
The level of evidence required depends on the strength of the claim. For nutritional claims within the END framework, you should hold ingredient-level evidence from published literature supporting the nutritional role you are describing. For therapeutic claims that you want to make under the END exclusion (rather than by registering), the APVMA requires scientific evidence of a standard suitable for publication in recognised peer-reviewed journals. Under the ACL, any claim must be substantiable, meaning you need evidence that a reasonable person would consider adequate to support the specific representation you are making. Building the evidence file before writing the marketing copy is always cheaper than defending a claim after the fact.
Is there a mandatory standard for pet food in Australia?
No. Australia does not currently have a mandatory federal standard for pet food. The Australian Standard AS 5812 covers manufacturing and labelling but is voluntary. A Senate committee has recommended expanding mandatory oversight of the pet food sector, and this recommendation remains active. In the absence of a mandatory standard, the Australian Consumer Law's general prohibition on misleading or deceptive conduct serves as the primary regulatory constraint on pet food claims and marketing.
How Parallaxis helps
Mapping the regulatory picture is the first step, but the harder work is translating it into claims that are both defensible and commercially effective. That means grading each claim against the right regulatory threshold, matching evidence to claim strength, building a substantiation file that holds up if the ACCC comes asking, and structuring your launch so the regulatory work accelerates your time to market rather than delaying it. That is where Parallaxis comes in. If you would like a hand building a claims and evidence strategy for your pet supplement or functional pet food brand, get in touch.